Bone Metastases
📧 Sign up to get email alerts when something new happens for Bone Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases [Phase 3]
This clinical trial update reports a Phase III randomized trial comparing stereotactic body radiation therapy (SBRT) to conventional palliat…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain [Phase 1]
Phase 1 clinical trial evaluating a samarium-based radiopharmaceutical intended to provide long-lasting analgesia for cancer-related bone pa…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
This clinical trial update reports on efforts to improve Bayesian survival estimates for patients needing surgery for bone metastases, spons…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating SHR-2017 Injection for prevention of bone events in patients with bone metastases from solid tumors; the…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
Clinical trial registry update for a Bone Metastases Registry evaluating cryoablation with curative intent in patients with bone metastases,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks [Phase 3]
This Phase 3 trial update compares denosumab given every 4 weeks versus every 12 weeks for prevention of symptomatic skeletal events in pati…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
A clinical trial assessing fracture risk in bone metastases derived from carcinoma is currently recruiting. The document provides an update …
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis [NA]
The document reports that a clinical trial evaluating palliative radiation therapy to reduce pain in patients with bone metastases has compl…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study of SKB107 in Advanced Solid Tumors With Bone Metastases [Phase 1]
Phase 1 clinical trial of SKB107 in advanced solid tumors with bone metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases [NA]
This clinical trial update describes an ongoing study evaluating standard treatment with or without SBRT for solid tumors that have 1 to 5 b…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases [Phase 1]
Phase 1 PK/PD study of SHR-2017 Injection in patients with bone metastases has completed.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial [NA]
The PERFORM trial compares proximal femur reconstruction versus internal fixation for bone metastases and is currently recruiting.
-
EMA approval · 2025-11-06EMA Authorised: Quadramet (samarium (153Sm) lexidronam pentasodium) — CIS bio international
EMA authorised Quadramet (samarium-153 lexidronam pentasodium) for the palliation of bone pain in cancer patients with bone metastases.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases [NA]
University of Utah is conducting a clinical trial evaluating simulation-free, single-fraction palliative radiation therapy for bone metastas…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery [Phase 1]
Phase 1 clinical trial evaluating salvage re-irradiation of spinal metastases using single-fraction stereotactic radiosurgery; currently act…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Validation of Whole Body PET/CT Foundation Model
Clinical trial update on validating a whole-body PET/CT foundation model for detecting bone metastases; the study is currently not yet recru…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology [Phase 4]
Phase 4 clinical trial comparing low molecular weight heparin versus aspirin for venous thromboembolism prophylaxis in orthopedic oncology, …
-
EMA approval · 2025-09-25EMA Authorised: Zoledronic acid Teva (zoledronic acid) — Teva B.V.
The EMA authorised Teva B.V.'s Zoledronic acid product for bone-related conditions and cancer-related bone disease. The active substance is …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality [NA]
Clinical trial update describes a spinal irradiation study aimed at palliation of neoplastic analgesia and improved life quality. The study …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy [NA]
Completed results are posted for the EPIBONE study, a prospective evaluation of the EPIBONE system's feasibility, safety, and accuracy in bo…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy
A clinical trial evaluating Dual Energy CT to delineate tumors and organs at risk in radiotherapy planning; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases [Phase 1]
Phase 1 clinical trial evaluating biology-guided radiation therapy for patients with bone metastases; the study is currently recruiting.
-
FDA approval · 2025-09-16FDA Approved: BOSAYA — Original Application (Biocon Biologics Inc.)
FDA approved BOSAYA (denosumab-kyqq) from Biocon Biologics Inc. under an Original Application as a biosimilar to denosumab products, with th…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Research on the Optimization of Treatment for Spinal Metastases With Radioactive Particle Implantation Using TPS and Mechanical Dual Simulation [NA]
A recruiting clinical trial evaluating optimization of radioactive particle implantation for spinal metastases in patients with advanced can…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: FDG PET/CT in Breast Cancer Bone Mets
A study evaluating FDG PET/CT imaging in estrogen receptor-positive breast cancer with bone metastases is currently active but not recruitin…